Saw palmetto

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Saw palmetto
Accession Number
DB14360
Type
Biotech
Groups
Approved, Experimental, Investigational
Description

Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Synonyms
  • Abal Fructus
  • Brahea Serrulata Fruit
  • Chamaerops Serrulata Fruit
  • Corypha Obliqua Fruit
  • Corypha Repens Fruit
  • Diglossophyllum Serrulatum Fruit
  • Sabal Palm Fruit
  • Sabal Serrulata
  • Sabal Serrulata Fruit
  • Sabalis Serrulatae Fructus (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
  • Saw Palmetto Berry
  • Saw Palmetto Extract
  • Saw Palmetto Fruit
  • Saw Palmetto Fruit (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
  • Saw Palmetto Fruit Extract
  • Serenoa
  • Serenoa Preparation
  • Serenoa Repens Fruit
  • Serenoa Repens Fruit Dry Extract
  • Serenoa Repens Fruit Ethanol Extract
  • Serenoa Serrulata Fruit
  • Serenoa Serrulata Fruit Extract
  • Serenoa Serrulata Fruit Powder
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Ethical Herbals Urinary FlowCapsuleOralAshbury Research CorporationNot applicableNot applicableCanada
Saw Palmetto Berries 500mgCapsuleOralGeneral Nutrition Canada Inc.1999-12-172007-08-01Canada
Saw Palmetto Tincture - Liq 0.25 Gm/mlLiquidOralHolista Health (Canada) Inc.1996-12-312001-08-01Canada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-152017-10-15Us
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-162017-10-16Us
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-152017-10-15Us
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-162017-10-16Us
Categories
UNII
J7WWH9M8QS
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
RxNav
350488
Wikipedia
Serenoa
AHFS Codes
  • 92:01.00* — Herbs and Natural Products

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2CompletedTreatmentProstate Cancer1
2CompletedTreatmentProstate Cancer1
3CompletedTreatmentBenign Prostatic Hyperplasia (BPH)1
3CompletedTreatmentUrological1
4Unknown StatusTreatmentSexual Dysfunctions in Men With Benign Prostatic Hyperplasia1
Not AvailableUnknown StatusTreatmentAdrenergic Alpha-Antagonists / Prostatic Hyperplasia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
PowderTopical
CapsuleOral
LiquidNot applicable1 kg/1kg
LiquidOral
Capsule, coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on July 05, 2018 11:13 / Updated on March 30, 2020 22:56

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates